Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...
“Time-to-market is money,” says Lukas Kürten, Digital Innovation Manager at CPI. “If you’ve got a process that works, you’ve got to throw it into manufacturing, because you’ve got to milk your patent ...
The president-elect might bring back efforts to make other countries pay more for drugs, but there are pitfalls.
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's potential impact on NGENF's stock value.
Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities.
Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for ...
New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.
Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
The flourishing gray market for intoxicating hemp products like Delta-8 is harming the legal cannabis market while ...
The high sales figures for gastric drugs reflect a growing health concern in Bangladesh related to dietary habits and lifestyle choices ...